Is hormone replacement therapy worth the risks? Subscription
The risks and benefits of hormone replacement therapy (HRT) have long been the source of confusion and controversy. Here we summarise the latest evidence to assist pharmacists in supporting patients thinking about HRT.
Pharmacy's ethnicity pay gap widens Subscription
As the government consults on whether to make reporting of ethnicity pay data mandatory for employers, our analyses show the extent of the ethnicity pay gap among pharmacists.
Hay fever: OTC management Subscription
More patients may seek advice on hay fever in the future since NHS England has advised GPs not to routinely prescribe products that are available over the counter for this condition.
Opioids in England: crisis averted? Subscription
Despite a 20% increase in opioid prescriptions per 1,000 population over the past decade, there are signs that a US-style opioid epidemic may have been averted.
MMR: the struggle for national coverage Subscription
Introduction of a measles vaccine in 1968 has reduced annual cases in England from around 460,000 to less than 1,000. However, the levels of vaccine coverage needed to eradicate measles remain elusive.
Measuring the market Subscription
There has been a slight contraction in the community pharmacy market in Great Britain since 2016, with small multiples winning out over large multiples and independent pharmacies
An overview of joint pain for community pharmacy teams.
Medication errors: where do they happen? Subscription
Reducing medicines-related harm requires a clear understanding of where and when errors occur. This visual summary shows the latest estimates in England per year.
The Carter review: how are hospitals measuring up? Subscription
Two years on from Lord Carter’s 2016 review of hospital efficiency, Electronicjuice looks at the progress pharmacy departments in England are making towards meeting his challenging targets.
Pharmacy 2018: The twists and turns Subscription
The main events in pharmacy throughout 2018 and a preview of the year ahead.